Novocure (NVCR) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
NovoCure Ltd. (NVCR) PT Raised to $28 at Mizuho Securities Citing Potential for CMS Reimbursement Approval
February 23, 2018 4:44 AM ESTMizuho Securities raised its price target on NovoCure Ltd. (NASDAQ: NVCR) to $28.00 (from $25.00) while maintaining a Buy rating.
... More